Agency selected because of performance history and a deep understanding of the company's healthcare, technology, and lifestyle spaces. RICHLAND, WA / ACCESSWIRE / March 1, 2022 / GlobeStar Therapeutics...
Agency selected because of performance history and a deep understanding of the company's healthcare, technology, and lifestyle spaces. RICHLAND, WA / ACCESSWIRE / March 1, 2022 / GlobeStar Therapeutics...
Company will work with its team of professionals to determine if our proprietary medical treatment will help Parkinson's patients as well. RICHLAND, WA / ACCESSWIRE / February 4, 2022 / GlobeStar Therapeutics...
Company will move from the Pink tier to QB tier effective immediately while retaining the same ticker symbol. RICHLAND, WA / ACCESSWIRE / October 11, 2021 / GlobeStar Therapeutics Corporation (OTCQB:GSTC)...
Company has made progress with a major medical center in the Northeast and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / October 4, 2021 / GlobeStar Therapeutics Corporation...
Company has made progress with a major medical center in the Northeast and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / October 4, 2021 / GlobeStar Therapeutics Corporation...
Company has made significant progress and identified a path forward for this pharmaceutical. RICHLAND, WA / ACCESSWIRE / September 20, 2021 / GlobeStar Therapeutics Corporation (OTCBB: GSTC) has filed...
New website goes live in tandem with a major branding campaign to be found in USA Today. RICHLAND, WA / ACCESSWIRE / July 21, 2021 / GlobeStar Therapeutics Corporation (OTC PINK:GSTC) is launching its...
RICHLAND, WA / ACCESSWIRE / July 15, 2021 / GlobeStar Therapeutics Corporation has partnered with the Washington Football Team Yearbook producers for inclusion in their annual book. GlobeStar Therapeutics...
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC...